RT10 — Retatrutide 10mg
Janoshik report #198419 · Lot RT10260605 · Analysed 10 July 2026
| Retatrutide | 11.51 mg / 11.62 mg / 11.39 mg |
|---|---|
| Purity | 99.717% / 99.155% / 99.524% |
Third-party analysis by Janoshik Analytical. Each entry below reproduces the figures exactly as they appear on the report, with the task number and a link you can use to check the result against the laboratory's own records rather than against this page.
Janoshik report #198419 · Lot RT10260605 · Analysed 10 July 2026
| Retatrutide | 11.51 mg / 11.62 mg / 11.39 mg |
|---|---|
| Purity | 99.717% / 99.155% / 99.524% |
Janoshik report #206717 · Lot RT20-260709 · Analysed 23 July 2026
| Retatrutide | 23.82 mg / 24.26 mg / 29.29 mg |
|---|---|
| Purity | 99.576% / 99.660% / 99.624% |
Endotoxin — separate analysis
| Endotoxin | 1.454 EU/vial |
|---|---|
| Report | #206718, analysed 22 July 2026 |
Janoshik report #193677 · Lot RT30-260610 · Analysed June 2026
| Retatrutide | 35.74 mg / 35.65 mg / 35.47 mg |
|---|
Endotoxin — separate analysis
| Endotoxin | 6.488 EU/vial |
|---|---|
| Report | #193678, analysed 24 June 2026 |
Janoshik report #217472 · Lot RT40-260804 · Analysed 20 August 2026
| Retatrutide | 44.93 mg / 45.35 mg / 44.70 mg |
|---|---|
| Purity | 99.896% / 99.860% / 99.877% |
Endotoxin — separate analysis
| Endotoxin | <1 EU/vial |
|---|---|
| Report | #217473, analysed 20 August 2026 |
Janoshik report #219495 · Lot RT50-260806 · Analysed 21 August 2026
| Retatrutide | 57.63 mg / 57.93 mg / 57.03 mg |
|---|---|
| Purity | 99.675% / 99.629% / 99.669% |
Endotoxin — separate analysis
| Endotoxin | <1 EU/vial |
|---|---|
| Report | #219496, analysed 20 August 2026 |
Janoshik report #219497 · Lot RT60-260807 · Analysed 21 August 2026
| Retatrutide | 67.17 mg / 67.34 mg / 68.52 mg |
|---|---|
| Purity | 99.692% / 99.625% / 99.554% |
Endotoxin — separate analysis
| Endotoxin | <1 EU/vial |
|---|---|
| Report | #219498, analysed 20 August 2026 |
Janoshik report #224829 · Lot T12-260819 · Analysed 7 September 2026
| Tirzepatide | 16.98 mg / 17.07 mg / 17.09 mg |
|---|---|
| Purity | 99.743% / 99.747% / 99.725% |
Endotoxin — separate analysis
| Endotoxin | 3.795 EU/vial |
|---|---|
| Report | #224830, analysed 7 September 2026 |
Janoshik report #222824 · Lot T60-260812 · Analysed 25 August 2026
| Tirzepatide | 66.90 mg / 66.64 mg / 65.95 mg |
|---|---|
| Purity | 99.471% / 99.523% / 99.472% |
Endotoxin — separate analysis
| Endotoxin | <1 EU/vial |
|---|---|
| Report | #222825, analysed 25 August 2026 |
Janoshik report #169182 · Lot Klow-260522 · Analysed May 2026
| GHK-Cu | 48.72 mg |
|---|---|
| TB-500 (TB-4) | 12.54 mg |
| BPC-157 | 10.34 mg |
| KPV | 11.67 mg |
Endotoxin — separate analysis
| Endotoxin | 3.680 EU/vial |
|---|---|
| Report | #169183, analysed 6 June 2026 |
Janoshik report #172243 · Lot Motsc40-260601 · Analysed June 2026
| MOTS-c | 44.09 mg / 42.73 mg / 43.08 mg |
|---|
Janoshik report #229511 · Lot MS10-260829 · Analysed 9 September 2026
| MOTS-c | 9.92 mg / 10.16 mg / 10.40 mg |
|---|---|
| Purity | 98.462% / 98.562% / 98.624% |
Endotoxin — separate analysis
| Endotoxin | <1 EU/vial |
|---|---|
| Report | #229512, analysed 9 September 2026 |
Janoshik report #125482 · Lot NAD260327 · Analysed 2026
| NAD+ | 532.45 mg / 531.25 mg / 533.64 mg |
|---|
Janoshik report #172248 · Lot GHK100-260604 · Analysed June 2026
| GHK-Cu | 82.10 mg / 82.16 mg / 86.25 mg |
|---|---|
| Purity | 99.187% / 99.298% / 99.208% |
Endotoxin — separate analysis
| Endotoxin | 2.065 EU/vial |
|---|---|
| Report | #172249, analysed 24 June 2026 |
Janoshik report #193683 · Lot Tesa-260610 · Analysed June 2026
| Tesamorelin | 22.21 mg / 21.16 mg / 21.15 mg |
|---|---|
| Purity | 99.039% / 98.808% / 98.821% |
Endotoxin — separate analysis
| Endotoxin | 6.123 EU/vial |
|---|---|
| Report | #193684, analysed 24 June 2026 |
Janoshik report #193680 · Lot Tesa-260609 · Analysed 26 June 2026
| Tesamorelin | 11.60 mg / 11.57 mg / 11.79 mg |
|---|---|
| Purity | 98.282% / 98.181% / 98.270% |
Endotoxin — separate analysis
| Endotoxin | 1.464 EU/vial |
|---|---|
| Report | #193681, analysed 24 June 2026 |
Janoshik report #212958 · Lot BB-260724 · Analysed 7 August 2026
| BPC-157 | 12.24 mg / 11.57 mg / 11.98 mg |
|---|---|
| TB-500 (TB-4) | 11.57 mg / 11.33 mg / 11.35 mg |
Endotoxin — separate analysis
| Endotoxin | 1.442 EU/vial |
|---|---|
| Report | #212959, analysed 6 August 2026 |
Janoshik report #212960 · Lot TB-260724 · Analysed 7 August 2026
| TB-500 (TB-4) | 10.94 mg / 11.01 mg / 10.60 mg |
|---|---|
| Purity | 99.380% / 99.389% / 99.313% |
Endotoxin — separate analysis
| Endotoxin | 1.597 EU/vial |
|---|---|
| Report | #212961, analysed 6 August 2026 |
Janoshik report #224833 · Lot PT-260820 · Analysed 9 September 2026
| PT-141 | 11.24 mg / 10.96 mg / 11.33 mg |
|---|---|
| Purity | 99.541% / 99.648% / 99.557% |
Endotoxin — separate analysis
| Endotoxin | 2.763 EU/vial |
|---|---|
| Report | #224834, analysed 7 September 2026 |
Janoshik report #224837 · Lot KPV-260822 · Analysed 9 September 2026
| KPV | 11.66 mg / 11.67 mg / 11.67 mg |
|---|---|
| Purity | 99.455% / 99.440% / 99.584% |
Janoshik report #224835 · Lot SS-260821 · Analysed 9 September 2026
| SS-31 | 10.17 mg / 10.11 mg / 10.18 mg |
|---|---|
| Purity | 99.851% / 99.762% / 99.824% |
Endotoxin — separate analysis
| Endotoxin | 3.850 EU/vial |
|---|---|
| Report | #224836, analysed 7 September 2026 |
Janoshik report #222826 · Lot Dsip-260813 · Analysed 25 August 2026
| DSIP | 11.96 mg / 11.54 mg / 11.16 mg |
|---|---|
| Purity | 98.949% / 98.989% / 98.969% |
Endotoxin — separate analysis
| Endotoxin | 1.475 EU/vial |
|---|---|
| Report | #222827, analysed 25 August 2026 |
Janoshik report #164552 · Lot 5amino-260510 · Analysed 17 June 2026
| 5-Amino-1-methylquinolinium | 44.81 mg / 44.12 mg / 45.22 mg |
|---|
Janoshik report #229509 · Lot T30-260830 · Analysed 9 September 2026
| Tirzepatide | 35.57 mg / 35.48 mg / 35.04 mg |
|---|---|
| Purity | 99.944% / 99.962% / 99.980% |
Endotoxin — separate analysis
| Endotoxin | <1 EU/vial |
|---|---|
| Report | #229510, analysed 9 September 2026 |
Janoshik report #214665 · Lot KX-260727 · Analysed 6 August 2026
| Selank | 11.51 mg / 11.87 mg / 11.78 mg |
|---|---|
| Semax | 12.13 mg / 12.34 mg / 12.43 mg |
Janoshik report #214664 · Lot Cag-260727 · Analysed 6 August 2026
| Cagrilintide | 5.25 mg / 5.28 mg / 5.35 mg |
|---|---|
| Purity | 99.840% / 99.803% / 99.782% |
Lot releases
We write when a new lot goes live with its third-party certificate of analysis. Nothing else, and you can unsubscribe in one click.